71288-166 : Pemetrexed 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 71288-166
Labeler: Meitheal Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Pemetrexed
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA208696
Rev. Date: 


NDC Package Codes:

  • 71288-166-10: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (71288‑166‑10) > 10 ML IN 1 VIAL, SINGLE‑DOSE
  • 71288-166-91: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (71288‑166‑91) / 10 ML IN 1 VIAL, SINGLE‑DOSE
  • 71288-166-92: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (71288‑166‑92) / 10 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Pemetrexed Disodium Hemipentahydrate

Dosage Strength:

  • 100 mg/10mL

Pharmaceutical Classes:

  • Folate Analog Metabolic Inhibitor [EPC]
  • Folic Acid Metabolism Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 71288-145 Pemetrexed 100 mg/4.2ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 71288-146 Pemetrexed 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 71288-147 Pemetrexed 750 mg/30ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 71288-148 Pemetrexed 1 g/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 71288-167 Pemetrexed 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 0338-0720 Pemetrexed 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0338-0722 Pemetrexed 500 mg/50ml Intraventricular Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0409-0004 Pemetrexed 1 g/40ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-0020 Pemetrexed 100 mg/4ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-0021 Pemetrexed 500 mg/20ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-1045 Pemetrexed 100 mg/4ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-1060 Pemetrexed 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-1061 Pemetrexed 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-1062 Pemetrexed 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-2188 Pemetrexed 500 mg/20ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-3532 Pemetrexed 1 g/40ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0480-4514 Pemetrexed 25 mg/ml Intravenous Solution, Concentrate by Teva Pharmaceuticals, Inc.
  • 0480-4515 Pemetrexed 25 mg/ml Intravenous Solution, Concentrate by Teva Pharmaceuticals, Inc.
  • 0480-4516 Pemetrexed 25 mg/ml Intravenous Solution, Concentrate by Teva Pharmaceuticals, Inc.
  • 0781-3518 Pemetrexed 100 mg/4ml Intravenous Injection, Solution by Sandoz Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71288-166 QR Code

< Prev: 71288-165Next: 71288-167 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.